DPD Exon-14 Skipping mutation test
Company
Oncoscreen GmbH
Use
To identify Exon 14-Skipping Mutation in the DPD-gene for cancer patients.
Features
Could help substantially reduce health care expenses
NIH Contribution
Devised methods and compositions useful for detecting deficiencies in dihydropyrimidine dehydrogenase (DPD) levels in humans
HHS Institute/Agency
NCI
Inventor(s)
F. Gonzales P. Fernandez-Salguero
Year
2002
Tech Cat
Diagnostic
Request More Info
